These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 623272)

  • 21. Cardiac resuscitation with hydrogen peroxide.
    Urschel HC; Morales AR; Finney JW; Balla GA; Race GJ; Mallams JT
    Ann Thorac Surg; 1966 Sep; 2(5):665-82. PubMed ID: 5970805
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model.
    Das B; Sarkar C
    Vascul Pharmacol; 2007 Oct; 47(4):248-56. PubMed ID: 17728191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbon monoxide and lethal arrhythmias.
    Farber JP; Schwartz PJ; Vanoli E; Stramba-Badiale M; De Ferrari GM
    Res Rep Health Eff Inst; 1990 Dec; (36):1-17; discussion 19-27. PubMed ID: 2092724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
    Gandhi C; Upaganalawar A; Balaraman R
    Free Radic Res; 2009 Sep; 43(9):817-27. PubMed ID: 19579067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment with tetrandrine has protective effects against isoproterenol-induced myocardial infarction in rabbits.
    Pinelli A; Trivulzio S; Brenna S; Galmozzi G; Rossoni G
    In Vivo; 2010; 24(3):265-70. PubMed ID: 20554997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. oxicity of diphenylhyntoin in dogs with experimental myocardial infarction.
    Nigri A; da Costa BC; Scriabine A; Bellet S; Germiniani H
    Cardiologia (Basel); 1968; 53(3):150-7. PubMed ID: 5736953
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.
    Imagawa J; Yellon DM; Baxter GF
    Br J Pharmacol; 1999 Feb; 126(3):701-8. PubMed ID: 10188982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional myocardial blood flow during nicotine infusion: effects of beta adrenergic blockade, and acute coronary artery occlusion.
    Downey HF; Bashour CA; Boutros IS; Bashour FA; Parker PE
    J Pharmacol Exp Ther; 1977 Jul; 202(1):55-68. PubMed ID: 17730
    [No Abstract]   [Full Text] [Related]  

  • 29. Beneficial cardiac effects of cicletanine in conscious rabbits with metabolic syndrome.
    Drimba L; Hegedüs C; Yin D; Sári R; Németh J; Szilvássy Z; Peitl B
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):208-18. PubMed ID: 22622233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of vagal suppression on early arrhythmias following experimental myocardial infarction in dogs.
    Nieto Lluis C; García Pérez M; Dorticós Balea F; Cabrera Santos A
    Cor Vasa; 1978; 20(6):379-85. PubMed ID: 747921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological delayed preconditioning against ischaemia-induced ventricular arrhythmias: effect of an adenosine A(1)-receptor agonist.
    Tissier R; Souktani R; Parent de Curzon O; Lellouche N; Henry P; Giudicelli JF; Berdeaux A; Ghaleh B
    Br J Pharmacol; 2001 Dec; 134(7):1532-8. PubMed ID: 11724760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The circulatory response to lidocaine in experimental myocardial infarction.
    Robison SL; Schroll M; Harrison DC
    Am J Med Sci; 1969 Oct; 258(4):260-9. PubMed ID: 5823462
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemodynamic and metabolic effects of hyperbaric oxygenation in myocardial infarction.
    Kline HJ; Marano AJ; Johnson CD; Goodman P; Jacobson JH; Kuhn LA
    J Appl Physiol; 1970 Mar; 28(3):256-63. PubMed ID: 5414754
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of oxygen-derived free radicals in canine reperfusion arrhythmias.
    Euler DE
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H295-300. PubMed ID: 7840275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of ischemic injury by nitroglycerin during acute myocardial infarction.
    Epstein SE; Kent KM; Goldstein RE; Borer JS; Redwood DR
    N Engl J Med; 1975 Jan; 292(1):29-35. PubMed ID: 803223
    [No Abstract]   [Full Text] [Related]  

  • 37. [Beta-receptor blockers in acute myocardial infarction].
    Hamm C
    Dtsch Med Wochenschr; 1990 Nov; 115(47):1811. PubMed ID: 1977572
    [No Abstract]   [Full Text] [Related]  

  • 38. Quinidine for prophylaxis of arrhythmias in acute myocardial infarction.
    Bloomfield SS; Romhilt DW; Chou TC; Fowler NO
    N Engl J Med; 1971 Oct; 285(18):979-86. PubMed ID: 4937690
    [No Abstract]   [Full Text] [Related]  

  • 39. Autonomic response to coronary occlusion in animals susceptible to ventricular fibrillation.
    Collins MN; Billman GE
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H1886-94. PubMed ID: 2603974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of halothane on arrhythmias induced by myocardial ischaemia.
    MacLeod BA; McGroarty R; Morton RH; Walker MJ
    Can J Anaesth; 1989 May; 36(3 Pt 1):289-94. PubMed ID: 2720866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.